Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams.
Rifampin in picogram quantities inhibited the ability of Mycobacterium bovis 44 BCG P3 to release 14CO2 from the oxidation of [14C]palmitic acid. By using these mycobacteria in a bioassay, samples of serum and posterior tibial nerve were assayed for inhibitory concentrations of rifampin. Within 8 to 12 h after ingestion of 600 mg of rifampin, the drug was detected in eight patients in concentrations ranging from 0.52 to 4.1 micrograms/ml in serum and in concentrations ranging from 0.6 to 6.3 ng/mg in posterior tibial nerve fiber tissue.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001681:Biological Assay; D006801:Humans; D007917:Leprostatic Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D007918:Leprosy / Q000382:microbiology; D008875:Middle Aged; D009163:Mycobacterium bovis / Q000187:drug effects / Q000378:metabolism; D009417:Nerve Tissue / Q000378:metabolism*; D010084:Oxidation-Reduction; D010169:Palmitic Acids / Q000378:metabolism; D012293:Rifampin / Q000493:pharmacokinetics* / Q000494:pharmacology; D013979:Tibial Nerve / Q000378:metabolism
D007917:Leprostatic Agents; D010169:Palmitic Acids; D012293:Rifampin